Cargando…

A pilot study of fecal bile acid and microbiota profiles in inflammatory bowel disease and primary sclerosing cholangitis

INTRODUCTION: Inflammatory bowel disease (IBD) is thought to arise from an abnormal immune response to the gut microbiota. IBD is associated with altered intestinal microbial community structure and functionality, which may contribute to inflammation and complications such as colon cancer and liver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaughn, Byron P, Kaiser, Thomas, Staley, Christopher, Hamilton, Matthew J, Reich, Jon, Graiziger, Carolyn, Singroy, Stephanie, Kabage, Amanda J, Sadowsky, Michael J, Khoruts, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330977/ https://www.ncbi.nlm.nih.gov/pubmed/30666146 http://dx.doi.org/10.2147/CEG.S186097

Ejemplares similares

Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection
por: Staley, Christopher, et al.
Publicado: (2019)

Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation
por: Staley, Christopher, et al.
Publicado: (2018)

Lower endoscopic delivery of freeze-dried intestinal microbiota results in more rapid and efficient engraftment than oral administration
por: Staley, Christopher, et al.
Publicado: (2021)

Primary sclerosing cholangitis – The arteriosclerosis of the bile duct?
por: Fickert, Peter, et al.
Publicado: (2007)

Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation
por: Staley, Christopher, et al.
Publicado: (2016)

Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022)

MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma
por: Voigtländer, Torsten, et al.
Publicado: (2015)

Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia
por: Pereira, Pedro, et al.
Publicado: (2017)

Primary sclerosing cholangitis.
por: Spence, R. A., et al.
Publicado: (1984)

Mutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis
por: Hov, Johannes R., et al.
Publicado: (2010)

Healthy Donor Fecal Microbiota Transplantation for Recurrent Bacterial Cholangitis in Primary Sclerosing Cholangitis – A Single Case Report
por: Philips, Cyriac Abby, et al.
Publicado: (2018)

Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth
por: Weingarden, Alexa R., et al.
Publicado: (2016)

IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis
por: Tanaka, Atsushi
Publicado: (2019)

Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation
por: Shankar, Vijay, et al.
Publicado: (2014)

Primary Sclerosing Cholangitis with Inflammatory Bowel Disease in Korean Children
por: Yoon, Jisun, et al.
Publicado: (2015)

Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review
por: Da Cunha, Teresa, et al.
Publicado: (2022)

Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease
por: Kim, You Sun, et al.
Publicado: (2023)

Quantitative bile and serum proteomics for the screening and differential diagnosis of primary sclerosing cholangitis
por: Holm, Matilda, et al.
Publicado: (2022)

Pathogenesis of primary sclerosing cholangitis
por: Pollheimer, Marion J., et al.
Publicado: (2011)

Primary sclerosing cholangitis
por: Worthington, Joy, et al.
Publicado: (2006)

Boosting corrects a memory B cell defect in SARS-CoV-2 mRNA–vaccinated patients with inflammatory bowel disease
por: Pape, Kathryn A., et al.
Publicado: (2022)

Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
por: Lynch, Kate D., et al.
Publicado: (2020)

Primary sclerosing cholangitis and pregnancy
por: Kammeijer, Casper Q., et al.
Publicado: (2011)

Environmental chemicals and endogenous metabolites in bile of USA and Norway patients with primary sclerosing cholangitis
por: Grant, Caroline W, et al.
Publicado: (2023)

Dietary Factors in Sulfur Metabolism and Pathogenesis of Ulcerative Colitis
por: Teigen, Levi M., et al.
Publicado: (2019)

High-affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines
por: Pape, Kathryn A., et al.
Publicado: (2021)

Psychological Features in the Inflammatory Bowel Disease–Irritable Bowel Syndrome Overlap: Developing a Preliminary Understanding of Cognitive and Behavioral Factors
por: Petrik, Megan, et al.
Publicado: (2021)

Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis
por: Tietz-Bogert, Pamela S., et al.
Publicado: (2018)

Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile
por: Vedeld, Hege Marie, et al.
Publicado: (2021)

Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
por: Fousekis, Fotios S., et al.
Publicado: (2019)

Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence
por: Mertz, Andrew, et al.
Publicado: (2019)

The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
por: Lynch, Kate D., et al.
Publicado: (2019)

Primary sclerosing cholangitis and the path to translation
por: Váncza, Lóránd, et al.
Publicado: (2023)

Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis
por: Tabibian, James H., et al.
Publicado: (2013)

Treatment of primary sclerosing cholangitis in children
por: Laborda, Trevor J, et al.
Publicado: (2019)

The immunobiology of primary sclerosing cholangitis
por: Aron, Jonathan H., et al.
Publicado: (2009)

Sclerosing Cholangitis in Behçet's Disease
por: Ben Slama Trabelsi, Aida, et al.
Publicado: (2013)

An Overview on Primary Sclerosing Cholangitis
por: Vlăduţ, Cătălina, et al.
Publicado: (2020)

The Covert Surge: Murine Bile Acid Levels Are Associated With Pruritus in Pediatric Autoimmune Sclerosing Cholangitis
por: Meinel, Katharina, et al.
Publicado: (2022)

Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis
por: Braadland, Peder Rustøen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_489o7ivb1u5ds6vr5ccn3luk2v